Evidence map›Paper›PMID 20716113›Full record

ArticleJournal of cellular and molecular medicine2011

Epac as a novel effector of airway smooth muscle relaxation.

Sara S Roscioni, Harm Maarsingh, Carolina R S Elzinga, Janke Schuur, Mark Menzen, Andrew J Halayko, Herman Meurs, Martina Schmidt

Open access · bronzeAbstract read
In one paragraph

Article in Journal of cellular and molecular medicine, 2011. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 42 papers.

0numbers the graph read from it
0cells of the map it votes in
42citing papers in PubMed
3.1field-weighted citation impact, top 8% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

42 citing papers in PubMed, 72 citations in OpenAlex.

  1. Long-acting βRespiratory research · 2025
    Article
  2. Review
  3. Review
  4. Article
  5. Article
  6. Review
  7. Article
  8. Article
  9. Regulation of P2X1 receptors by modulators of the cAMP effectors PKA and EPAC.Proceedings of the National Academy of Sciences of the United States of America · 2021
    Article
  10. Review
  11. Article
  12. Review
  13. Integration of Rap1 and Calcium Signaling.International journal of molecular sciences · 2020
    Review
  14. Article
  15. Article
  16. Article
  17. Review
  18. Epac Function and cAMP Scaffolds in the Heart and Lung.Journal of cardiovascular development and disease · 2018
    Review
  19. Prostaglandin EMolecular pharmacology · 2017
    Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 2 institutions in 2 countries.

Sara S RoscioniDepartment of Molecular Pharmacology, University of Groningen, Antonius Deusinglaan 1, Groningen, The Netherlands. s.s.roscioni@rug.nl
Harm Maarsingh
Carolina R S Elzinga
Janke Schuur
Mark Menzen
Andrew J Halayko
Herman Meurs
Martina Schmidt
University of Groningen · NLUniversity of Manitoba · CA

Funding

Canadian Institutes of Health Research
6 · The paper itself

Abstract

Dysfunctional regulation of airway smooth muscle tone is a feature of obstructive airway diseases such as asthma and chronic obstructive pulmonary disease. Airway smooth muscle contraction is directly associated with changes in the phosphorylation of myosin light chain (MLC), which is increased by Rho and decreased by Rac. Although cyclic adenosine monophosphate (cAMP)-elevating agents are believed to relieve bronchoconstriction mainly via activation of protein kinase A (PKA), here we addressed the role of the novel cAMP-mediated exchange protein Epac in the regulation of airway smooth muscle tone. Isometric tension measurements showed that specific activation of Epac led to relaxation of guinea pig tracheal preparations pre-contracted with methacholine, independently of PKA. In airway smooth muscle cells, Epac activation reduced methacholine-induced MLC phosphorylation. Moreover, when Epac was stimulated, we observed a decreased methacholine-induced RhoA activation, measured by both stress fibre formation and pull-down assay whereas the same Epac activation prevented methacholine-induced Rac1 inhibition measured by pull-down assay. Epac-driven inhibition of both methacholine-induced muscle contraction by Toxin B-1470, and MLC phosphorylation by the Rac1-inhibitor NSC23766, were significantly attenuated, confirming the importance of Rac1 in Epac-mediated relaxation. Importantly, human airway smooth muscle tissue also expresses Epac, and Epac activation both relaxed pre-contracted human tracheal preparations and decreased MLC phosphorylation. Collectively, we show that activation of Epac relaxes airway smooth muscle by decreasing MLC phosphorylation by skewing the balance of RhoA/Rac1 activation towards Rac1. Therefore, activation of Epac may have therapeutical potential in the treatment of obstructive airway diseases.

Indexed as

AnimalsCell Adhesion MoleculesCells, CulturedCyclic AMPGuanine Nucleotide Exchange FactorsGuinea PigsHumansIsoproterenolMaleMicrofilament ProteinsMuscle RelaxationMuscle, SmoothMyocytes, Smooth MuscleMyosin Light ChainsPhosphoproteinsrac1 GTP-Binding ProteinCell Adhesion MoleculesCyclic AMPGuanine Nucleotide Exchange FactorsIsoproterenolMicrofilament ProteinsMyosin Light ChainsPhosphoproteinsrac1 GTP-Binding ProteinrhoA GTP-Binding ProteinVasodilator-Stimulated Phosphoprotein

Identifiers

PMID20716113
PMCPMC3823199
OpenAlexW2022498785

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.